178 related articles for article (PubMed ID: 24615628)
21. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.
Lai JI; Wang WS
Pharm World Sci; 2009 Oct; 31(5):538-541. PubMed ID: 19588266
[TBL] [Abstract][Full Text] [Related]
22. Renal toxicity of oxaliplatin.
Labaye J; Sarret D; Duvic C; Hérody M; Didelot F; Nédélec G; Noël LH
Nephrol Dial Transplant; 2005 Jun; 20(6):1275-6. PubMed ID: 15827046
[No Abstract] [Full Text] [Related]
23. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
24. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
25. An immediate hemolytic reaction induced by repeated administration of oxaliplatin.
Chen VM; Thrift KM; Morel-Kopp MC; Jackson D; Ward CM; Flower RL
Transfusion; 2004 Jun; 44(6):838-43. PubMed ID: 15157248
[TBL] [Abstract][Full Text] [Related]
26. A case of acute tubular necrosis due to oxaliplatin.
Pinotti G; Martinelli B
Ann Oncol; 2002 Dec; 13(12):1951-2. PubMed ID: 12453866
[No Abstract] [Full Text] [Related]
27. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.
Gordon LI; Kwaan HC
Semin Thromb Hemost; 1999; 25(2):217-21. PubMed ID: 10357089
[TBL] [Abstract][Full Text] [Related]
29. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome-related complex in a patient with metastatic prostate cancer?
Shrestha A; Khosla P; Wei Y
Am J Ther; 2011 Sep; 18(5):e167-71. PubMed ID: 20592666
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.
Jackson AM; Rose BD; Graff LG; Jacobs JB; Schwartz JH; Strauss GM; Yang JP; Rudnick MR; Elfenbein IB; Narins RG
Ann Intern Med; 1984 Jul; 101(1):41-4. PubMed ID: 6203452
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
[TBL] [Abstract][Full Text] [Related]
33. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function.
Massari C; Brienza S; Rotarski M; Gastiaburu J; Misset JL; Cupissol D; Alafaci E; Dutertre-Catella H; Bastian G
Cancer Chemother Pharmacol; 2000; 45(2):157-64. PubMed ID: 10663631
[TBL] [Abstract][Full Text] [Related]
35. Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report.
Soma Y; Kawabe T; Kitaji D; Hoshino K; Sunohara S; Iwano T; Kawano N
BMC Nephrol; 2023 Mar; 24(1):76. PubMed ID: 36978021
[TBL] [Abstract][Full Text] [Related]
36. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
[TBL] [Abstract][Full Text] [Related]
37. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
[TBL] [Abstract][Full Text] [Related]
38. Renal tubular acidosis due to oxaliplatin.
Linch M; Cunningham D; Mingo O; Stiles A; Farquhar-Smith WP
Ann Oncol; 2007 Apr; 18(4):805-6. PubMed ID: 17389529
[No Abstract] [Full Text] [Related]
39. Oxaliplatin-induced acute thrombocytopenia.
Erdem GU; Dogan M; Demirci NS; Zengin N
J Cancer Res Ther; 2016; 12(2):509-14. PubMed ID: 27461601
[TBL] [Abstract][Full Text] [Related]
40. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
